Atay Oguzhan, an officer and director at BillionToOne, Inc., has filed a notice to sell 8,333 shares of Class A stock. This transaction, valued at approximately $983,294, is part of a stock option exercise. The filing indicates that the sale will take place on October 28, 2026.

BillionToOne, Inc. is classified under the SIC code for medical laboratories, reflecting its focus on providing innovative laboratory services. The company is based in Menlo Park, California, and is publicly traded on NASDAQ under the SEC file number 001-42934. Recent filings show a series of transactions by Oguzhan, indicating active management of his stock holdings.

The SEC filing reveals that Oguzhan acquired the 8,333 shares through a stock option exercise on the same day as the sale. The filing states, "Atay Oguzhan is selling 8,333 shares of Class A stock for cash." This sale is part of a broader trend where executives exercise stock options and subsequently sell shares to realize gains.

This transaction may impact other stakeholders, including investors and analysts monitoring executive actions within the medical laboratories industry. It reflects ongoing trends in executive compensation and stock liquidity, which are critical for understanding market dynamics.

The filing does not say what happens next regarding Oguzhan's remaining stock options or any future transactions.